TENAX THERAPEUTICS, INC. Notes Payable, Noncurrent
TENAX THERAPEUTICS, INC. (TENX) had Notes Payable, Noncurrent of $31.08 thousand as of 2021-03-31, per its 10-Q filed 2021-05-17.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Long-Term Debt, Excluding Current Maturities › Notes and Loans, Noncurrent
us-gaap:LongTermNotesPayable · last filed 2021-05-17
- 2021-03-31: Notes Payable, Noncurrent $31.08K.
- 2020-12-31: Notes Payable, Noncurrent $124.17K.
- 2020-09-30: Notes Payable, Noncurrent $213.76K.
- 2020-06-30: Notes Payable, Noncurrent $137.05K.
| Period end | Notes Payable, Noncurrent |
|---|---|
| 2021-03-31 | $31.08K 10-Q · filed 2021-05-17 |
| 2020-12-31 | $124.17K 10-Q · filed 2021-05-17 |
| 2020-09-30 | $213.76K 10-Q · filed 2020-11-16 |
| 2020-06-30 | $137.05K 10-Q · filed 2020-08-14 |
| 2019-12-31 | $0.00 10-K/A · filed 2021-04-16 |
| 2014-04-30 | $0.00 10-K · filed 2014-07-29 |
| 2014-01-31 | $0.00 10-Q · filed 2014-03-17 |
| 2013-10-31 | $0.00 10-Q · filed 2013-12-17 |
| 2013-04-30 | $2.99M 10-K · filed 2014-07-29 |
| 2013-01-31 | $2.59M 10-Q · filed 2013-03-18 |
| 2012-10-31 | $2.18M 10-Q · filed 2012-12-14 |
| 2012-07-31 | $1.77M 10-Q · filed 2012-09-19 |
| 2012-04-30 | $1.36M 10-K · filed 2013-06-26 |
| 2012-01-31 | $952.78K 10-Q · filed 2012-03-15 |
| 2011-10-31 | $6.18M 10-Q · filed 2011-12-15 |
| 2011-07-31 | $5.53M 10-Q · filed 2011-09-19 |
| 2011-04-30 | $4.46M 10-K · filed 2012-07-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |